Filter Results:
(5,557)
Show Results For
- All HBS Web
(5,557)
- People (16)
- News (2,009)
- Research (2,714)
- Events (8)
- Multimedia (211)
- Faculty Publications (1,909)
Show Results For
- All HBS Web
(5,557)
- People (16)
- News (2,009)
- Research (2,714)
- Events (8)
- Multimedia (211)
- Faculty Publications (1,909)
- April 2020
- Supplement
Luvo (B)
By: José B. Alvarez and Natalie Kindred
This case, a follow on to HBS No. 517-049 "Luvo," provides a brief look at changes that have occurred at Luvo, now called Performance Kitchen, since the timing of the first case (mid-2016). Set in January 2020, “Luvo (B)” touches on developments such as the company's... View Details
Keywords: Consumer Behavior; Health; Health Care and Treatment; Nutrition; Food; Strategy; Product Positioning; Product Marketing; Food and Beverage Industry; Agriculture and Agribusiness Industry; Consumer Products Industry; Retail Industry; United States; Canada
Alvarez, José B., and Natalie Kindred. "Luvo (B)." Harvard Business School Supplement 520-101, April 2020.
- 27 Aug 2013
- First Look
First Look: August 27
of inflation increases demand for cost of living adjustments. Frames that highlight flexibility, control, and investment significantly reduce annuitization. A majority of respondents prefer to receive an extra "bonus" payment... View Details
Keywords: Sean Silverthorne
- 07 Jun 2014
- Video
Ebru Dorman - Making A Difference
- June 1994 (Revised March 1995)
- Case
Lotus Development Corp.: Spousal Equivalents (A)
A group of Lotus employees propose extending all health care and other benefits to the spousal equivalents of lesbian and gay employees. The vice president of human resources considers the proposal during a reorganization and period of financial uncertainty. View Details
Gentile, Mary C., and Sarah Gant. "Lotus Development Corp.: Spousal Equivalents (A)." Harvard Business School Case 394-197, June 1994. (Revised March 1995.)
- 13 Mar 2023
- Research & Ideas
The Power of Personal Connections: How Shared Experiences Boost Performance
residency, including on metrics such as patients’ likelihood of recommending their specialist, write Maximilian J. Pany, a doctoral candidate at Harvard Business School and MD candidate at Harvard Medical School, and J. Michael McWilliams, Warren Alpert Foundation... View Details
- 23 Jan 2020
- News
Five Ways Hospitals Will Change in Next Decade
- 06 Apr 2021
- News
Day of 4 Million Vaccines Signals Sharp Turnaround for U.S.
- September 8, 2020
- Article
Allocation of COVID-19 Relief Funding to Disproportionately Black Counties
By: Pragya Kakani, Amitabh Chandra and Sendhil Mullainathan
This study describes correlations between the dollar amount of relief funding authorized by the US Congress to fund prevention, diagnosis, and treatment of coronavirus disease 2019 (COVID-19) and to reimburse health care entities for lost revenues, and county-level... View Details
Kakani, Pragya, Amitabh Chandra, and Sendhil Mullainathan. "Allocation of COVID-19 Relief Funding to Disproportionately Black Counties." JAMA, the Journal of the American Medical Association 324, no. 10 (September 8, 2020): 1000–1003.
- February 2015 (Revised November 2015)
- Supplement
Building an Integrated Biopharma Company: Crucell (B)
By: Richard G. Hamermesh, Marianne Van Der Steen and Susan Harmeling
The Crucell (B) case updates events at Crucell since 2009. In September, 2009, Johnson & Johnson acquired 18% of Crucell for $400 million. This investment was part of a business development deal. Subsequently, in 2012, Johnson & Johnson acquired Crucell for $2.8... View Details
Keywords: Biotechnology; Biopharmacy Company; Licensing Agreements In Biopharmacy; Licensing; Human Cell-line Technology; Vaccine; Healthcare Innovation; Global Health; Entrepreneurship; Health Care and Treatment; Acquisition; Innovation and Invention; Biotechnology Industry; Pharmaceutical Industry
Hamermesh, Richard G., Marianne Van Der Steen, and Susan Harmeling. "Building an Integrated Biopharma Company: Crucell (B)." Harvard Business School Supplement 815-086, February 2015. (Revised November 2015.)
- 09 Mar 2009
- Research & Ideas
How to Revive Health-Care Innovation
The patient is weak, the situation is serious, but a cure is on the horizon—if we think differently about the underlying problem. Specifically, we need to innovate in health care just the way it is done in... View Details
- 27 Nov 2017
- News
Payment Reform Is a Play We’re All Watching
- February 2010 (Revised March 2012)
- Case
U.S. Healthcare Reform: International Perspectives
By: Arthur A. Daemmrich and Elia Cameron
The national economic implications of rising healthcare costs were poorly understood, even as the United States, Germany, and the United Kingdom instituted reforms in early 2010. Presenting opportunities for cross-national policy learning, this case describes the... View Details
Keywords: Macroeconomics; Insurance; Governing Rules, Regulations, and Reforms; Health Care and Treatment; Laws and Statutes; Business and Government Relations; Health Industry; Health Industry; Germany; United Kingdom; United States
Daemmrich, Arthur A., and Elia Cameron. "U.S. Healthcare Reform: International Perspectives." Harvard Business School Case 710-040, February 2010. (Revised March 2012.)
- 03 Feb 2015
- Working Paper Summaries
Regulator Leniency and Mispricing in Beneficent Nonprofits
- 01 Jul 2020
- News